Medline completes acquisition of Hudson RCI® respiratory products

High-quality respiratory consumables deepen Medline portfolio

By Medline Newsroom Staff | June 28, 2021

Medline has completed the acquisition of a significant portion of the Hudson RCI® brand of respiratory consumables from Teleflex. The sale, announced last month, includes the brand’s oxygen and aerosol therapy, active humidification, non-invasive ventilation (NIV) and incentive spirometer products.

Medline will integrate these product categories into its respiratory portfolio, enhancing an already powerful offering which performed exceptionally well during the COVID- 19 pandemic at meeting the growing respiratory care needs across the healthcare continuum.

“The addition of the highly-regarded Hudson RCI® line of products broadens our portfolio of world-class respiratory solutions that are designed to empower best practices and deliver the uncompromising quality and performance required to care for the complex needs of patients,” said Donna Mosakowski, Medline division vice president.

Learn more about how Medline is transforming the way respiratory care is delivered and experienced.

 

 

Share

Medline Newsroom Staff

Medline Newsroom Staff

Medline's newsroom staff researches and reports on the latest news and trends in healthcare.

View All Stories From This Author